333 related articles for article (PubMed ID: 19968662)
1. Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.
Zaza G; Granata S; Sallustio F; Grandaliano G; Schena FP
Clin Exp Immunol; 2010 Mar; 159(3):268-80. PubMed ID: 19968662
[TBL] [Abstract][Full Text] [Related]
2. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pharmacogenomics: Applications in Nephrology.
Adams SM; Crisamore KR; Empey PE
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1561-1571. PubMed ID: 29793969
[TBL] [Abstract][Full Text] [Related]
4. A conceptual framework for pharmacodynamic genome-wide association studies in pharmacogenomics.
Wu R; Tong C; Wang Z; Mauger D; Tantisira K; Szefler SJ; Chinchilli VM; Israel E
Drug Discov Today; 2011 Oct; 16(19-20):884-90. PubMed ID: 21920452
[TBL] [Abstract][Full Text] [Related]
5. Symposium "Clinical Pharmacology Anno 2008". 10th Heymans Memorial Lecture.
Van Bortel L
Verh K Acad Geneeskd Belg; 2009; 71(6):315-34. PubMed ID: 20232787
[TBL] [Abstract][Full Text] [Related]
6. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics and pharmacogenomics: development, science, and translation.
Weinshilboum RM; Wang L
Annu Rev Genomics Hum Genet; 2006; 7():223-45. PubMed ID: 16948615
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L
Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
10. Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.
Chan SL; Jin S; Loh M; Brunham LR
Pharmacogenomics; 2015; 16(10):1161-78. PubMed ID: 25978008
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics: a systems approach.
Wang L
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(1):3-22. PubMed ID: 20836007
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics: from discovery to patient care.
Shin J; Kayser SR; Langaee TY
Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
[TBL] [Abstract][Full Text] [Related]
13. Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital.
La Russa R; Fineschi V; Di Sanzo M; Gatto V; Santurro A; Martini G; Scopetti M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):274-281. PubMed ID: 28176638
[TBL] [Abstract][Full Text] [Related]
14. Genetic signatures in the treatment of stroke.
Munshi A; Sharma V
Curr Pharm Des; 2015; 21(3):343-54. PubMed ID: 25163728
[TBL] [Abstract][Full Text] [Related]
15. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
[TBL] [Abstract][Full Text] [Related]
16. Drug target pharmacogenomics: an overview.
Johnson JA
Am J Pharmacogenomics; 2001; 1(4):271-81. PubMed ID: 12083959
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
Evans WE; Johnson JA
Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
[TBL] [Abstract][Full Text] [Related]
18. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia.
Kager L
J BUON; 2009 Sep; 14 Suppl 1():S181-6. PubMed ID: 19785064
[TBL] [Abstract][Full Text] [Related]
19. Evolution of pharmacogenomics.
Somogy A
Proc West Pharmacol Soc; 2008; 51():1-4. PubMed ID: 19544663
[TBL] [Abstract][Full Text] [Related]
20. Pediatric perspective on pharmacogenomics.
Stevens A; De Leonibus C; Hanson D; Whatmore A; Murray P; Donn R; Meyer S; Chatelain P; Clayton P
Pharmacogenomics; 2013 Nov; 14(15):1889-905. PubMed ID: 24236488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
